-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, QqSOMusY9eMn7KKW2VkfeVCPqFVDvb15uxYA2rlIjMOkK1nKWuSpIGVvQqO1QHSE UtGVfqskNn4AI+Pi7yfwgg== 0001104659-04-026738.txt : 20040902 0001104659-04-026738.hdr.sgml : 20040902 20040902152600 ACCESSION NUMBER: 0001104659-04-026738 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20040901 FILED AS OF DATE: 20040902 DATE AS OF CHANGE: 20040902 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ABBOTT LABORATORIES CENTRAL INDEX KEY: 0000001800 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 360698440 STATE OF INCORPORATION: IL FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 ABBOTT PARK ROAD STREET 2: D-322 AP6D CITY: ABBOTT PARK STATE: IL ZIP: 60064-3500 BUSINESS PHONE: 8479376100 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LEIDEN JEFFREY M CENTRAL INDEX KEY: 0001242825 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-02189 FILM NUMBER: 041013778 BUSINESS ADDRESS: STREET 1: 100 ABBOT PARK RD CITY: ABBOTT PARK STATE: IL ZIP: 60064-6049 BUSINESS PHONE: 8479376100 4 1 a4.xml 4 X0202 4 2004-09-01 0 0000001800 ABBOTT LABORATORIES ABT 0001242825 LEIDEN JEFFREY M 100 ABBOTT PARK ROAD ABBOTT PARK IL 60064-6400 1 1 0 0 President and COO Common shares without par value 2004-09-01 4 M 0 15469 33.2314 A 290461 D Common shares without par value 2004-09-01 4 F 0 13569 41.69 D 276892 D Common shares without par value 612 I Profit Sharing Trust Option (right to buy) 33.2314 2004-09-01 4 M 0 15469 0 D 2004-02-14 2013-02-13 common shares 15469 449050 D Option (right to buy) 41.69 2004-09-01 4 A 0 13569 0 A 2005-03-02 2013-02-13 common shares 13569 13569 D Balance in the Abbott Laboratories Stock Retirement Trust as of September 1, 2004. Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. This exercise was made pursuant to a previously adopted plan complying with Rule 10b5-1(c). The plan was adopted on May 26, 2004. John A. Berry, Attorney-in-Fact for Jeffrey M. Leiden 2004-09-02 -----END PRIVACY-ENHANCED MESSAGE-----